ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Akari Therapeutics (AKTX)

Technical Analysis Report for NASDAQ stock AKTX Akari Therapeutics. Dated: 29 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock AKTX Akari Therapeutics then click here. or read Experts views on Akari Therapeutics or Forecast & share price targets of Akari Therapeutics

Akari Therapeutics Opened at 9.17 and Closed at: 8.00, which is -15% of previous session's close. It moved within a range of 8.00 and 9.83
The session was a Bearish session with an average volume of 97000, which is 56.49% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Golden cross was found 2 days back on short term averages

Support for tomorrow is 7.09 and resistance for tomorrow is 8.92
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 7.39, 6.78 resistance for tomorrow's hourly charts is 9.22, 10.44

10 Day SMA for Akari Therapeutics (AKTX) is 8.59 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Akari Therapeutics (AKTX) is 8.5 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Akari Therapeutics (AKTX) is 9.28 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 9.74 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Akari Therapeutics is 6.83 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Akari Therapeutics is at 8.5 and 200 DMA is at 6.83, while 50 DMA and 100 DMA are at 9.28 and 9.74 respectively

Akari Therapeutics (AKTX) moving average of 20 SMA is at 8.5 and 20 EMA is at 8.63

Akari Therapeutics (AKTX) moving average of 50 SMA is at 9.28 and 50 EMA is at 8.99

Akari Therapeutics (AKTX) moving average of 100 SMA is at 9.74 and 100 EMA is at 8.8

Akari Therapeutics (AKTX) moving average of 200 SMA is at 6.83 and 200 EMA is at 7.35

Akari Therapeutics has performed better than Syndax Pharmaceuticals in short term. Holding Akari Therapeutics could be a better choice for now!

Surgery Partners has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Surgery Partners, about 82.51% more returns!

Regenxbio Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Regenxbio Inc, about 7.99% more returns!

Regeneron Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Regeneron Pharmaceuticals, about 19.63% more returns!

Novavax Inc has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Novavax Inc, about 8.36% more returns!

Akari Therapeutics has performed better than Aceto Corporation in short term. Holding Akari Therapeutics could be a better choice for now!

Addus Homecare has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Addus Homecare, about 20.01% more returns!

Akari Therapeutics has performed better than Alnylam Pharmaceuticals in short term. Holding Akari Therapeutics could be a better choice for now!

Apyx Medical has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Apyx Medical, about 13.75% more returns!

Akari Therapeutics has performed better than Corcept Therapeutics in short term. Holding Akari Therapeutics could be a better choice for now!

Entera Bio has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Entera Bio, about 17.35% more returns!

Idexx Laboratories has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Idexx Laboratories, about 19.37% more returns!

Ionis Pharmaceuticals has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Ionis Pharmaceuticals, about 10.21% more returns!

Akari Therapeutics has performed better than Iovance Biotherapeutics in short term. Holding Akari Therapeutics could be a better choice for now!

Medpace Holdings has performed better than Akari Therapeutics in short term. You could have earned much better returns by investing in Medpace Holdings, about 21.29% more returns!

Akari Therapeutics Technical analysis of indicators

Price action analysis of Akari Therapeutics (AKTX) based on a short term time period is neutral. A longer time frame might give a better analysis.

ADX buy sell signal for Akari Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.

MACD generated a BUY signal for Akari Therapeutics in short term but the buy signal is initial and weak.

Akari Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Akari Therapeutics in short term and SELL signal is strong!

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Akari Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 8.62 and Akari Therapeutics AKTX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Akari Therapeutics AKTX stock. Volume based technical analysis of Akari Therapeutics AKTX stock is negative.

Akari Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock AKTX Akari Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And AKTX Experts View which covers a lot of information including buying and selling signals

AKTX future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Akari Therapeutics or View Candle Stick Charts here

Chart Akari Therapeutics (AKTX)  Technical (Analysis) Reports Akari Therapeutics [

Videos related to: Akari Therapeutics (AKTX) Technical (Analysis) Reports Akari Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Akari Therapeutics (AKTX)  Technical (Analysis) Reports Akari Therapeutics [

 

Back to top